down arrow

Bajaj Healthcare

52
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE411U01027
  • NSEID: BAJAJHCARE
  • BSEID: 539872
INR
580.50
18.35 (3.26%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.23 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -26.69% vs -5.01% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is -31.52% vs -6.02% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 69.01% vs 39.11% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is -122.55% vs -11.00% in Mar 2023

Compare Profit and Loss Results of Bajaj Healthcare
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
473.00
9,264.00
-8,791.00
-94.89%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
473.00
9,264.00
-8,791.00
-94.89%
Expenditure (Ex Depriciation)
Stock Adjustments
-9.00
-25.00
16.00
64.00%
Raw Materials Consumed
264.00
2,933.00
-2,669.00
-91.00%
Power & Fuel Cost
31.00
70.00
-39.00
-55.71%
Employee Cost
43.00
1,982.00
-1,939.00
-97.83%
Operating Expenses
40.00
143.00
-103.00
-72.03%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
806.00
-801.00
-99.38%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
8.00
136.00
-128.00
-94.12%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
397.00
6,939.00
-6,542.00
-94.28%
Operating Profit (PBDIT) excl Other Income
76.00
2,325.00
-2,249.00
-96.73%
Other Income
8.00
266.00
-258.00
-96.99%
Operating Profit (PBDIT)
84.00
2,592.00
-2,508.00
-96.76%
Interest
29.00
15.00
14.00
93.33%
Profit before Depriciation and Tax
55.00
2,577.00
-2,522.00
-97.87%
Depreciation
27.00
317.00
-290.00
-91.48%
Profit Before Taxation & Exceptional Items
27.00
2,259.00
-2,232.00
-98.80%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-16.00
2,259.00
-2,275.00
-100.71%
Provision for Tax
-2.00
436.00
-438.00
-100.46%
Profit After Tax
-14.00
1,823.00
-1,837.00
-100.77%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
353.00
7,868.00
-7,515.00
-95.51%
Profit Available for appropriations
339.00
9,691.00
-9,352.00
-96.50%
Appropriations
339.00
9,691.00
-9,352.00
-96.50%
Equity Dividend (%)
20%
0%
20.00
Earnings Per Share
-30.36
45.52
-75.88
-166.70%
Profit And Loss - Net Sales
Net Sales 473.42 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -26.69% vs -5.01% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 76.27 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -31.52% vs -6.02% in Mar 2023

Profit And Loss - Interest
Interest 29.68 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 69.01% vs 39.11% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax -14.33 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -122.55% vs -11.00% in Mar 2023